Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by SUVRETTA CAPITAL MANAGEMENT, LLC. Director active across 1 company, notably Benitec Biopharma Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 7 buys · 0 sell. Total volume traded: €27.7m. Activity tracked since 26 September 2024. The latest transaction was disclosed on 7 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.